Literature DB >> 2787409

Use of prophylactic antibiotics for prevention of intravascular catheter-related infections in interleukin-2-treated patients.

L C Hartmann1, W J Urba, R G Steis, J W Smith, L A Vander Molen, S P Creekmore, M Sznol, M A Casciano, N Engler, D L Longo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2787409     DOI： 10.1093/jnci/81.15.1190

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  2 in total

1.  Totally implanted catheters to reduce catheter-related infections in patients receiving interleukin-2: a 2-year experience.

Authors:  B Escudier; J L Lethiec; E Angevin; A Andremont; M F Cosset-Delaigue; S Antoun; B Leclercq; G Nitenberg
Journal:  Support Care Cancer       Date:  1995-09       Impact factor: 3.603

Review 2.  Biologics for Targeting Inflammatory Cytokines, Clinical Uses, and Limitations.

Authors:  Peleg Rider; Yaron Carmi; Idan Cohen
Journal:  Int J Cell Biol       Date:  2016-12-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.